Scotiabank lowered the firm’s price target on Sage Therapeutics (SAGE) to $12 from $14 and keeps an Outperform rating on the shares. The firm’s ...

Biogen shares fell, after the biotechnology company forecast lower-than-expected revenue and profit for this year, saying multiple-sclerosis drug sales will decline further and will only be partially ...

Biogen stock took a hit Wednesday after the biotech company issued light guidance for 2025 despite beating most fourth-quarter expectations.

The S&P 500 Index ($SPX) (SPY) today is down -0.91%, the Dow Jones Industrials Index ($DOWI) (DIA) is down -0.92%, and the ...

March S&P 500 E-Mini futures (ESH25) are trending down -1.08% this morning as investors digest key U.S. inflation data and also await further testimony from Federal Reserve Chair Jerome Powell.

January's Consumer Price Index (CPI) report saw inflation come out hotter than expected in the previous month. Morning Brief ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/2.3cY8rBmp.js ...

Wall Street stocks were lower early on Wednesday as traders digested a hotter-than-expected January consumer inflation report ...